A retrospective analysis of longitudinal changes in bone mineral content in cystic fibrosis

Insights

Bone mineral content decreases over time in most children with cystic fibrosis (CF). Factors like lung function and vitamin D levels impact bone health, suggesting targets for intervention.

Area of Science:

  • Pediatrics
  • Bone Metabolism
  • Cystic Fibrosis Research

Background:

  • Cystic Fibrosis (CF) is associated with suboptimal bone health.
  • Longitudinal changes in bone mineral content (BMC) and influencing factors in pediatric CF patients require detailed description.

Purpose of the Study:

  • To investigate the longitudinal changes in bone mineral content (BMC) in children with cystic fibrosis (CF).
  • To identify factors influencing bone mineral content (BMC) over time in this population.

Main Methods:

  • Dual-energy X-ray absorptiometry (DXA) was used to assess bone mineral content standard deviation score (LSBMCSDS) in 100 children over 10 years.
  • Retrospective collection of disease markers, anthropometry, and bone biochemistry data.
  • LSBMCSDS was adjusted for age, gender, ethnicity, and bone area.

Main Results:

  • Most children with CF exhibited suboptimal baseline bone mineral content (BMC) or decreasing values over time.
  • Lower forced expiratory volume in 1 second percent (FEV1%), low body mass index standard deviation scores (BMI SDS), and vitamin D levels were associated with BMC reduction.
  • Despite individual decreases, the mean LSBMCSDS did not show a statistically significant decline over the study period.

Conclusions:

  • Bone mineral content (BMC) is frequently suboptimal and tends to decrease over time in children with cystic fibrosis (CF).
  • Pulmonary function (FEV1%), nutritional status (BMI SDS), and vitamin D levels are key factors influencing bone health in CF.
  • Addressing these identified parameters presents opportunities to improve bone health outcomes in pediatric CF patients.
Abstract

Related Concept Videos

Cystic Fibrosis: Pathogenesis01:23

Cystic Fibrosis: Pathogenesis

Cystic fibrosis (CF), an autosomal recessive disorder, significantly affects the function of exocrine glands. This genetically inherited disease is characterized by the production of thick and sticky mucus, which can severely affect various organs and systems in the body.
CF is primarily caused by a genetic mutation in a chromosome 7 gene coding for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. The most common gene mutation leading to CF is the ΔF508 mutation,...
966
Cystic Fibrosis: Management01:24

Cystic Fibrosis: Management

Cystic fibrosis (CF) is an autosomal recessive disorder that predominantly affects individuals of Northern European descent, occurring at a rate of 1 in 3500. It is caused by a genetic mutation in a gene on chromosome 7, most commonly the ΔF508 mutation, that codes for the cystic fibrosis transmembrane conductance regulator (CFTR) protein. This results in thicker mucus secretions and obstruction pathologies in multiple organs, including the lungs and sinuses.
Sinus disease and chronic...
593
Bone Disorders01:29

Bone Disorders

Aging and its effect on bone remodeling is the most common cause of bone disorders. In young and healthy people, bone deposition and resorption happen at an equal rate to maintain optimal bone health.
Bone deposition is also affected by the levels of sex hormones like estrogen and testosterone that promote osteoblast activity and bone matrix synthesis. When the level of these hormones decreases due to aging, it causes a reduction in bone deposition. As a result, bone resorption by osteoclasts...
5.8K